Results 191 to 200 of about 20,692 (311)

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab? [PDF]

open access: gold, 2020
Carlo Mümmler   +4 more
openalex   +1 more source

Reappraising the clinical impact of mepolizumab [PDF]

open access: yes, 2017
Chupp   +5 more
core   +2 more sources

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang   +22 more
wiley   +1 more source

Alopecia Areata Associated with Dupilumab: National Database Study. [PDF]

open access: yesDiagnostics (Basel)
Sontam T   +6 more
europepmc   +1 more source

Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series

open access: yes
International Journal of Dermatology, EarlyView.
Christine Bangert   +4 more
wiley   +1 more source

Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [PDF]

open access: hybrid, 2020
Eric D. Bateman   +10 more
openalex   +1 more source

Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review. [PDF]

open access: yesDiseases
Guerriero C   +8 more
europepmc   +1 more source

Dupilumab facial redness: Positive effect of itraconazole

open access: gold, 2019
Fleur S.A. de Beer   +6 more
openalex   +1 more source

Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials [PDF]

open access: hybrid, 2020
S. Barbarot   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy